Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
Probing human sperm metabolism using 13 C-magnetic resonance spectroscopy
Because most challenges happen in everyday life, support needs to be practical, personal and long term
Copper toxicity concerns are generally minimal with topical applications due to limited systemic absorption
Phase 2 trial data (published in New England Journal of Medicine, 2023 ): 24.2% average weight loss at 48 weeks with 12 mg dose 22.8% with 8 mg dose Placebo group lost 2.1% Most recent Phase 3 trial data (TRIUMPH-4, December 2025): 28.7% average weight loss at 68 weeks with 12 mg dose 26.4% with 9 mg dose 58.6% of participants on 12 mg achieved at least 25% weight loss 39.4% achieved at least 30% weight loss For context: These are the highest weight loss numbers reported in any clinical trial for a pharmacological obesity treatment
US$ 24.85
US$ 20.70
US$ 21.04
US$ 20.72
